| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |